Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Degarelix Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 120 mg per vial
  • 1.4.3 80 mg per vial
• 1.5 Market by Application
  • 1.5.1 Global Degarelix Market Share by Application (2014-2025)
  • 1.5.2 Hospital
  • 1.5.3 Drug store
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Degarelix Market Size
• 2.2 Degarelix Growth Trends by Regions
  • 2.2.1 Degarelix Market Size by Regions (2014-2025)
  • 2.2.2 Degarelix Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Opportunities

3 Market Share by Key Players

• 3.1 Degarelix Market Size by Manufacturers
  • 3.1.1 Global Degarelix Revenue by Manufacturers (2014-2019)
  • 3.1.2 Global Degarelix Revenue Market Share by Manufacturers (2014-2019)
  • 3.1.3 Global Degarelix Market Concentration Ratio (CR5 and HHI)
• 3.2 Degarelix Key Players Head office and Area Served
• 3.3 Key Players Degarelix Product/Solution/Service
• 3.4 Date of Enter into Degarelix Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Degarelix Market Size by Type (2014-2019)
• 4.2 Global Degarelix Market Size by Application (2014-2019)

5 United States

• 5.1 United States Degarelix Market Size (2014-2019)
• 5.2 Degarelix Key Players in United States
• 5.3 United States Degarelix Market Size by Type
• 5.4 United States Degarelix Market Size by Application

6 Europe

• 6.1 Europe Degarelix Market Size (2014-2019)
• 6.2 Degarelix Key Players in Europe
• 6.3 Europe Degarelix Market Size by Type
• 6.4 Europe Degarelix Market Size by Application

7 China

• 7.1 China Degarelix Market Size (2014-2019)
• 7.2 Degarelix Key Players in China
• 7.3 China Degarelix Market Size by Type
• 7.4 China Degarelix Market Size by Application

8 Japan

• 8.1 Japan Degarelix Market Size (2014-2019)
• 8.2 Degarelix Key Players in Japan
• 8.3 Japan Degarelix Market Size by Type
• 8.4 Japan Degarelix Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Degarelix Market Size (2014-2019)
• 9.2 Degarelix Key Players in Southeast Asia
• 9.3 Southeast Asia Degarelix Market Size by Type
• 9.4 Southeast Asia Degarelix Market Size by Application

10 India

• 10.1 India Degarelix Market Size (2014-2019)
• 10.2 Degarelix Key Players in India
• 10.3 India Degarelix Market Size by Type
• 10.4 India Degarelix Market Size by Application

11 Central & South America

• 11.1 Central & South America Degarelix Market Size (2014-2019)
• 11.2 Degarelix Key Players in Central & South America
• 11.3 Central & South America Degarelix Market Size by Type
• 11.4 Central & South America Degarelix Market Size by Application

12 International Players Profiles

• 12.1 Ferring
  • 12.1.1 Ferring Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Degarelix Introduction
  • 12.1.4 Ferring Revenue in Degarelix Business (2014-2019)
  • 12.1.5 Ferring Recent Development

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Regions
• 13.2 United States
• 13.3 Europe
• 13.4 China
• 13.5 Japan
• 13.6 Southeast Asia
• 13.7 India
• 13.8 Central & South America
• 13.9 Market Size Forecast by Product (2019-2025)
• 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 12.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer

Degarelix (INN) or degarelix acetate (USAN), sold under the brand name Firmagon among others, is a hormonal therapy used in the treatment of prostate cancer.
In 2018, the global Degarelix market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Degarelix status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Degarelix development in United States, Europe and China.

The key players covered in this study
Ferring
...

Market segment by Type, the product can be split into
120 mg per vial
80 mg per vial

Market segment by Application, split into
Hospital
Drug store

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Degarelix status, future forecast, growth opportunity, key market and key players.
To present the Degarelix development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Degarelix are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.